Agilent Rule 144 Notice: 2,000 Shares Intended Sale on NYSE

Rhea-AI Filing Summary

Form 144 filing for Agilent Technologies, Inc. (A): The filer notified an intended sale of 2,000 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $249,760.00, with an approximate sale date of 09/02/2025 on the NYSE. The schedule lists the acquisition of smaller blocks of restricted stock that vested between 11/14/2023 and 05/19/2024 (totaling 2,000 shares listed). The filing also discloses two prior sales by the same person in 07/2025 (1,508 shares) and 08/2025 (2,000 shares) with gross proceeds shown.

Insights

Securities Analyst

TL;DR: Routine insider sale notice showing modest planned disposition and recent past sales; not a company earnings or operational disclosure.

The Form 144 documents a proposed sale of 2,000 Agilent shares valued at $249,760 via Fidelity, and lists the original acquisitions as restricted stock vesting events in late 2023 and mid-2024. It also records two recent sales in July and August 2025 totaling 3,508 shares with reported gross proceeds. From a trading disclosure perspective this is a compliance filing that notifies the market of intended insider liquidity activity; it does not provide operational or financial performance data.

Corporate Governance Expert

TL;DR: Filing fulfills Rule 144 disclosure for insider sales; shows vesting-based holdings being monetized but contains no governance changes.

The submission lists vesting as the origin of the securities being sold, indicating these shares were received as compensation. The filer attests to lack of undisclosed material information. There is no indication of management departure, transaction with related parties, or a 10b5-1 plan date provided. As a governance disclosure, it is routine and informational.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2000	249760.00	283500427	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/14/2023	Restricted Stock Vesting	Issuer			262	11/14/2023	Compensation
Common	11/15/2023	Restricted Stock Vesting	Issuer			400	11/15/2023	Compensation
Common	11/16/2023	Restricted Stock Vesting	Issuer			294	11/16/2023	Compensation
Common	11/17/2023	Restricted Stock Vesting	Issuer			403	11/17/2023	Compensation
Common	11/19/2023	Restricted Stock Vesting	Issuer			286	11/19/2023	Compensation
Common	05/19/2024	Restricted Stock Vesting	Issuer			355	05/19/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Padraig Mcdonnell 5301 Stevens Creek Blvd. Santa Clara CA 95051	Common	07/01/2025	1508	177099.52
Padraig Mcdonnell 5301 Stevens Creek Blvd. Santa Clara CA 95051	Common	08/01/2025	2000	226900.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Agilent Technologies (A) report?

The filing reports an intended sale of 2,000 common shares valued at $249,760.00, with an approximate sale date of 09/02/2025 on the NYSE.

How were the shares being sold acquired?

The shares were acquired through restricted stock vesting on dates between 11/14/2023 and 05/19/2024, listed as compensation.

Has the filer sold Agilent shares recently?

Yes. The filing discloses prior sales by the same person of 1,508 shares on 07/01/2025 (gross proceeds $177,099.52) and 2,000 shares on 08/01/2025 (gross proceeds $226,900.00).

Which broker will execute the proposed sale?

The broker named is Fidelity Brokerage Services LLC, address listed in Smithfield, RI, and the sale is to occur on the NYSE.

Does the filing state any 10b5-1 trading plan adoption date?

No. The form does not provide a date of plan adoption or instruction under Rule 10b5-1.